Use of noninvasive and invasive mechanical ventilation in cardiogenic shock: A prospective multicenter study
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články, multicentrická studie, randomizované kontrolované studie
PubMed
28043661
DOI
10.1016/j.ijcard.2016.12.175
PII: S0167-5273(16)34826-4
Knihovny.cz E-zdroje
- Klíčová slova
- Acute coronary syndrome, Acute myocardial infarction, Cardiogenic shock, Mechanical ventilation, Noninvasive ventilation, Ventilation,
- MeSH
- jednotky intenzivní péče * MeSH
- kardiogenní šok komplikace mortalita terapie MeSH
- lidé MeSH
- míra přežití trendy MeSH
- mortalita v nemocnicích trendy MeSH
- neinvazivní ventilace metody MeSH
- respirační insuficience etiologie mortalita terapie MeSH
- senioři MeSH
- umělé dýchání metody MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- randomizované kontrolované studie MeSH
- Geografické názvy
- Evropa epidemiologie MeSH
BACKGROUND: Despite scarce data, invasive mechanical ventilation (MV) is widely recommended over non-invasive ventilation (NIV) for ventilatory support in cardiogenic shock (CS). We assessed the real-life use of different ventilation strategies in CS and their influence on outcome focusing on the use of NIV and MV. METHODS: 219 CS patients were categorized by the maximum intensity of ventilatory support they needed during the first 24h into MV (n=137; 63%) , NIV (n=26; 12%), and supplementary oxygen (n=56; 26%) groups. We compared the clinical characteristics and 90-day outcome between the MV and the NIV groups. RESULTS: Mean age was 67years, 74% were men. The MV and NIV groups did not differ in age, medical history, etiology of CS, PaO2/FiO2 ratio, baseline hemodynamics or LVEF. MV patients predominantly presented with hypoperfusion, with more severe metabolic acidosis, higher lactate levels and greater need for vasoactive drugs, whereas NIV patients tended to be more often congestive. 90-day outcome was significantly worse in the MV group (50% vs. 27%), but after propensity score adjustment, mortality was equal in both groups. Confusion, prior CABG, ACS etiology, higher lactate level, and lower baseline PaO2 were independent predictors of mortality, whereas ventilation strategy did not have any influence on outcome. CONCLUSIONS: Although MV is generally recommended mode of ventilatory support in CS, a fair number of patients were successfully treated with NIV. Moreover, ventilation strategy was not associated with outcome. Thus, NIV seems a safe option for properly chosen CS patients.
Attikon University Hospital Heart Failure Clinic and Secondary Cardiology Department Athens Greece
Helsinki University Hospital Heart and Lung Center Division of Cardiology Helsinki Finland
Institute of Cardiology Intensive Cardiac Therapy Clinic Warsaw Poland
Rigshospitalet Copenhagen University Hospital Intensive Cardiac Care Unit Copenhagen Denmark
University Hospital Brno Department of Internal Medicine and Cardiology Brno Czech Republic
Citace poskytuje Crossref.org